References
Thomas, Jr., C.G., Cuenca, R.E., Azizkhan, R.G., Underwood, L.E., Carney, C.N.: Changing concepts of islet cell dysplasia in neonatal and infantile hyperinsulinism. World J. Surg.12:598, 1988
Goudswaard, W.B., Houthoff, H.J., Koudstaal, J., Zwierstra, R.P.: Nesidioblastosis and endocrine hyperplasia of the pancreas: A secondary phenomenon. Hum. Pathol.17:46, 1986
Gould, V.E., Chejfec, G., Shah, K., Paloyan, E., Lawrence, A.M.: Adult nesidiodysplasia. Semin. Diag. Pathol.1:43, 1984
Witte, D.P., Greider, M.H., De Schryver-Kecskemeti, K., Kissane, J.M., White, N.H.: The juvenile human endocrine pancreas: Normal versus idiopathic hyperinsulinemic hypoglycemia. Semin. Diag. Pathol.1:30, 1984
Jaffe, R., Hashida, Y., Yunis, E.J.: Pancreatic pathology in hyperinsulinemic hypoglycemia of infancy. Lab. Invest.42:356, 1980
Kramer, J.L., Bell, M.H., De Schryver, K., Bower, R.J., Ternberg, J.L., White, N.H.: Clinical and histologic indications for extensive pancreatic resection in nesidioblastosis. Am. J. Surg.143:116, 1982
Comi, R.J., Gorden, P., Doppman, J.L., Norton, J.A.: Insulinoma. In The Exocrine Pancreas: Biology, Pathobiology and Diseases, V.L.W. Go, editor, New York, Raven Press, 1986, p. 745
Bougneres, P.F., Landier, F., Garnier, P., Job, J.C., Chaussain, J.L.: Treatment of insulin excess by continuous subcutaneous infusion of somatostatin and glucagon in an infant. J. Pediatr.10:792, 1985
Telander, R.L., Wolf, S.A., Simmons, P.S., Zimmerman, D., Haymond, M.W.: Endocrine disorders of the pancreas and adrenal cortex in pediatric patients. Mayo Clin. Proc.61:459, 1986
Martin, L.W., Ryckman, F.C., Sheldon, C.A.: Experience with 95% pancreatectomy and splenic salvage for neonatal nesidioblastosis. Ann. Surg.200:355, 1984
Langer, J.C., Filler, R.M., Wesson, D.E., Sherwood, G., Cutz, E.: Surgical management of persistent neonatal hypoglycemia due to islet cell dysplasia. J. Pediatr. Surg.19:786, 1984
Hocking, M.D., Newell, S.J., Rayner, P.H.W.: Use of human growth hormone in the treatment of nesidioblastosis in a neonate. Arch. Dis. Child.61:706, 1986
McGraw, M.E., Price, D.A.: Complications of diazoxide in the treatment of nesidioblastosis. Arch. Dis. Child.60:62, 1985
Gillies, D.R.N.: Complications of diazoxide in the treatment of nesidioblastosis. Arch. Dis. Child.60:500, 1985
Hindmarsh, P., Brook, C.G.D.: Short-term management of nesidioblastosis using the somatostatin analgoue SMS 201-995. N. Engl. J. Med.316:221, 1987
Davidson, P.M., Young, D.G., Logan, R.W., Lockhart, S., Patrick, W.J.A.: Alloxan therapy for nesidioblastosis. J. Pediatr. Surg.19:87, 1984
Delemarre-van de Waal, H.A., Veldkamp, E.J.M., Schrander-Stumpel, C.T.R.M.: Long-term treatment of an infant with nesidioblastosis using a somatostatin analogue. N. Engl. J. Med.316:222, 1987
Jackson, J.A., Hahn, H.B., Oltorf, C.E., O'Dorisio, T.M., Vinik, A.E.: Long-term treatment of refractory neonatal hypoglycemia with long-acting somatostatin analog. J. Pediatr.4:548, 1987
Marx, S.J., Lasker, R.D., Brown, E.M., Fitzpatrick, L.A., Sweezey, N.B., Goldblood, R.B., Gillis, D.A., Cole, D.E.C.: Secretory dysfunction in parathyroid cells from a neonate with severe primary hyperparathyroidism. J. Clin. Endocrinol. Metab.62:445, 1985
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Norton, J.A., Stovroff, M.C. Invited commentary. World J. Surg. 12, 608–609 (1988). https://doi.org/10.1007/BF01655861
Issue Date:
DOI: https://doi.org/10.1007/BF01655861